Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis

New England Journal of Medicine

Volumn 322, Issue 12, 1990, Pages 802-809

  Riggs, B Lawrence ^a   Hodgson, Stephen F ^a   O'fallon, W Michael ^a   Chao, Edmund Y s ^a   Wahner, Heinz W ^a   Muhs, Joan M ^a   Cedel, Sandra L ^a   Melon, L Joseph ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORIDE SODIUM;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; BONE MINERAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECT; FEMALE; FEMUR; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIUS; SPINE; VERTEBRA FRACTURE;

EID: 0025374223     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199003223221203     Document Type: Article

References (39)

1. Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med 1986; 314: 1676–86.
2. Idem. Treatment of osteoporosis with sodium fluoride: an appraisal. In: Peck WA, ed. Bone and mineral research. Annual 2. New York: Elsevier, 1984:366–93.
3. Briancon D, Meunier PJ. Treatment of osteoporosis with fluoride, calcium, and vitamin D. Orthop Clin North Am 1981; 12: 629–48.
4. Grodberg MG. Transcripts of testimony before Advisory Committee Meeting, Food and Drug Administration, Rockville, Md., August 18, 1978.
5. Heaney RP, Baylink DJ, Johnston CC Jr, et al. Fluoride therapy for vertebral crush fracture syndrome: a status report. Ann Intern Med 1989; 111: 678–80.
6. Baylink DJ, Bernstein DS. The effects of fluoride therapy on metabolic bone disease: a histologic study. Clin Orthop 1967; 55: 51–85.
7. Jowsey J, Riggs BL, Kelly PJ, Hoffman DL. Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med 1972; 53: 43–9.
8. Gutteridge DH, Price RI, Nicholson GC, et al. Fluoride in osteoporotic vertebral fractures — trabecular increase, vertebral protection, femoral fractures. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL, eds. Osteoporosis: Copenhagen International Symposium on Osteoporosis, June 3–8, 1984. Vol. 2. Copenhagen: Department of Clinical Chemistry, Glostrup Hospital, 1984:705–7.
9. Hedlund LR, Gallagher JC. Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride. J Bone Miner Res 1989; 4: 223–5.
10. Riggs BL, Baylink DJ, Kleerekoper M, Lane JM, Melton LJ III, Meunier PJ. Incidence of hip fractures in osteoporotic women treated with sodium fluoride. J Bone Miner Res 1987; 2: 123–6.
11. Mamell N, Meunier PJ, Dusan R, et al. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 1988; 2: 361–5.
12. Duda RJ Jr. O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease. J Clin Endocrinol Metab 1988; 66: 951–7.
13. Fry BW, Taves DR. Serum fluoride analysis with the fluoride electrode. J Lab Clin Med 1970; 75: 1020–5.
14. Riggs BL, Wahner HW, Seeman E, et al. Changes in bone mineral density of the proximal femur and spine with aging: differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest 1982; 70: 716–23.
15. Chao EY, Laging BJ, Bleimeyer RR, Riggs BL. Biplanar stereo roentgenographic method for determining vertebral fracture in postmenopausal osteoporosis. Orthop Trans 1985; 9: 313. abstract.
16. Rab GT, Chao EY. Verification of roentgenographic landmarks in the lumbar spine. Spine 1977; 2: 287–93.
17. Cochran WG. Sampling techniques. 3rd ed. New York: John Wiley, 1977:153–6.
18. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika 1967; 54: 167–79.
19. McCullagh P. Regression models for ordinal data. J R Stat Soc [B] 1980; 42: 109–42.
20. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187–220.
21. Draper NR, Smith H. Applied regression analysis. 2nd ed. New York: John Wiley, 1981:108–16.
22. Halperin M, Lan KK, Wright EC, Foulkes MA. Stochastic curtailing for comparison of slopes in longitudinal studies. Controlled Clin Trials 1987; 8: 315–26.
23. Rüegsegger P, Rüegsegger E, Ittner J, Dambacher M. Natural course of osteoporosis and fluoride therapy — a longitudinal study using quantitative computed tomography. J Comput Assist Tomogr 1985; 9: 626–7. abstract.
24. Eanes ED, Reddi AH. The effect of fluoride on bone mineral apatite. Metab Bone Dis Rel Res 1979; 2: 3–10.
25. Wolinsky I, Simkin A, Guggenheim K. Effects of fluoride on metabolism and mechanical properties of rat bone. Am J Physiol 1972; 223: 46–50.
26. Rich C, Feist E. The action of fluoride on bone. In: Vischer TL, ed. Fluoride in medicine. Bern, Switzerland: Hans Huber, 1970:70–87.
27. Wolinsky I, Guggenheim KY. The effect of fluoride on the mechanical strength of bone. Baroda J Nutr 1976; 3: 177–88.
28. Riggins RS, Zeman F, Moon D. The effects of sodium fluoride on bone breaking strength. Calcif Tissue Res 1974; 14: 283–9.
29. Acute Leukemia Group B, Eastern Cooperative Oncology Group. Ineffectiveness of fluoride therapy in multiple myeloma. N Engl J Med 1972; 286: 1283–8.
30. Inkovaara J, Heikinheimo R, Jarvinen K, Kasurinen U, Hanhijarvi H, Iisalo E. Prophylactic fluoride treatment and aged bones. Br Med J 1975; 3: 73–4.
31. Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon WM. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis: comparison with conventional therapy. N Engl J Med 1982; 306: 446–50.
32. Dambacher MA, Ittner J, Rüegsegger P. Long-term fluoride therapy of postmenopausal osteoporosis. Bone 1986; 7: 199–205.
33. Gallagher JC, Riggs BL, Recker RR, Goldgar D. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med 1989; 191: 287–92.
34. Kleerekoper M, Peterson E, Philips E, Nelson D, Tilley B, Parfitt AM. Continuous sodium fluoride therapy does not reduce vertebral fracture rate in postmenopausal osteoporosis. J Bone Miner Res 1989; 4: Suppl 1: S376.
35. Martin AD, McCulloch RG. Bone dynamics: stress, strain and fracture. J Sports Sci 1987; 5: 155–63.
36. Schulz EE, Engstrom H, Sauser DD. Baylink DJ. Osteoporosis: radiographic detection of fluoride-induced extra-axial bone formation. Radiology 1986; 159: 457–62.
37. Schnitzler CM, Solomon L. Trabecular stress fractures during fluoride therapy for osteoporosis. Skeletal Radiol 1985; 14: 276–9.
38. O'Duffy JD, Wanner HW, O'Fallon WM, et al. Mechanism of acute lower extremity pain syndrome in fluoride-treated osteoporotic patients. Am J Med 1986; 80: 561–6.
39. Tilley BC, Kleerekoper M, Peterson EL, Phillips E, Nelson DA, Schork MA. Designing clinical trials of treatment for osteoporosis: recruitment and follow-up. Calcif Tissue Int (in press).